Samir el Bouazzati

Samir holds a Master’s degree in Neurobiology, which he obtained cum laude in 2024. He has a strong background in preclinical research, particularly in pharmacodynamics. Prior to joining DADA, Samir gained experience working in the health insurance sector. In 2024, he joined DADA as a member of the Safety Data Management team, where he conducts signal detection activities, including global literature screening and monitoring adverse drug reaction reports from regulatory authorities such as the EMA and MHRA.